A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists

被引:278
作者
Wilson, VS [1 ]
Bobseine, K [1 ]
Lambright, CR [1 ]
Gray, LE [1 ]
机构
[1] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Reprod Toxicol Div, Res Triangle Pk, NC 27711 USA
关键词
stable cell line; androgen receptor; glucocorticoid receptor; endocrine screening; antiandrogen; vinclozolin; p; p-DDE; linuron; procymidone; HPTE;
D O I
10.1093/toxsci/66.1.69
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The U.S. Environmental Protection Agency has proposed that in vitro assays for estrogen receptor (ER)- and androgen receptor (AR)-mediated actions be included in a Tier-I screening battery to detect hormonally active chemicals. Herein we describe the development of a novel stable cell line, MDA-kb2, for screening of androgen agonist and antagonists and to characterize its specificity and sensitivity to endocrine-disrupting chemicals. The breast cancer cell line, MDA-MB-453, was stably transformed with the MMTV.luciferase.neo reporter gene construct. Since both GR and AR are present in the MDA-MB-453 cells, and both receptors can act through the MMTV promoter, compounds that act through either AR or GR activate the MMTV luciferase reporter. As expected, AR agonists such as dihydrotestosterone (DHT), and GR agonists such as dexamethasone (DEX), corticosterone, and aldosterone induce luciferase expression at appropriate concentrations. DHT consistently produced 3-9-fold induction at concentrations from 0.1 to 10 nM. At 1 to 1000 nM, DEX induced luciferase activity 1.3-19.5-fold. To distinguish AR- from GR-mediated ligands, chemicals were assayed concurrently with the antiandrogen, hydroxyflutamide (OHF), which blocks AR- but not GR-mediated responses. In addition, known AR antagonists, including hydroxyflutamide, vinclozolin, vinclozolin metabolites M1 and M2, p,p'-DDE, and linuron inhibited DHT-induced luciferase gene expression at appropriate concentrations in this system. We have found that these cells are relatively easy to culture and maintain. Responsiveness was monitored over time and was stable for more than 80 passages. Some advantages of this assay are that it is relatively rapid (2 days), eliminates the need for transfection, can be conducted in a 96-well plate format, and produces consistent reproducible results. In summary, we have developed a cell line that can be used to screen chemicals, not just for AR- but for GR-mediated activities as well.
引用
收藏
页码:69 / 81
页数:13
相关论文
共 30 条
[1]  
ALLAN GF, 1992, J BIOL CHEM, V267, P19513
[2]  
[Anonymous], ADV MODERN ENV TOXIC
[3]  
BARDIN CW, 1984, PHARMACOL THERAPEUT, V23, P443
[4]   Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells [J].
Bentel, JM ;
Birrell, SN ;
Pickering, MA ;
Holds, DJ ;
Horsfall, DJ ;
Tilley, WD .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 154 (1-2) :11-20
[5]   ENVIRONMENTAL ESTROGENS - HEALTH IMPLICATIONS FOR HUMANS AND WILDLIFE [J].
COLBORN, T .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 :135-136
[6]   Interaction of methoxychlor and related compounds with estrogen receptor α and β, and androgen receptor:: structure-activity studies [J].
Gaido, KW ;
Maness, SC ;
McDonnell, DP ;
Dehal, SS ;
Kupfer, D ;
Safe, S .
MOLECULAR PHARMACOLOGY, 2000, 58 (04) :852-858
[7]   SWITCHING AGONISTIC, ANTAGONISTIC, AND MIXED TRANSCRIPTIONAL RESPONSES TO 11-BETA-SUBSTITUTED PROGESTINS BY MUTATION OF THE PROGESTERONE-RECEPTOR [J].
GARCIA, T ;
BENHAMOU, B ;
GOFFLO, D ;
VERGEZAC, A ;
PHILIBERT, D ;
CHAMBON, P ;
GRONEMEYER, H .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (12) :2071-2078
[8]   Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat [J].
Gray, LE ;
Wolf, C ;
Lambright, C ;
Mann, P ;
Price, M ;
Cooper, RL ;
Ostby, J .
TOXICOLOGY AND INDUSTRIAL HEALTH, 1999, 15 (1-2) :94-118
[9]  
Hadley M. E., 2007, Endocrinology, V6th ed.
[10]   REGULATION OF ANDROGEN RECEPTOR GENE-EXPRESSION BY STEROIDS AND RETINOIC ACID IN HUMAN BREAST-CANCER CELLS [J].
HALL, RE ;
TILLEY, WD ;
MCPHAUL, MJ ;
SUTHERLAND, RL .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) :778-784